Literature DB >> 22467266

Cancer among patients with diabetes, obesity and abnormal blood lipids: a population-based register study in Sweden.

Bo Attner1, Mona Landin-Olsson, Thor Lithman, Dennis Noreen, Håkan Olsson.   

Abstract

OBJECTIVE: To study how the incidence of cancer is related to diabetes, obesity or abnormal blood lipids.
METHODS: Diagnosis of diabetes, obesity or abnormal blood lipids was studied 0-10 years prior to the diagnosis of cancer in 19,756 cases of cancer and in 147,324 controls matched regarding age, sex and domicile.
RESULTS: Diabetes was significantly more common prior to diagnosis in patients with liver, pancreatic, colon and urinary tract/bladder cancer and in patients with breast cancer diagnosed with diabetes 0-4 years prior to the cancer diagnosis. A lower risk of diabetes was seen in patients with prostate carcinoma among individuals with diabetes diagnosed 5-10 years prior to the cancer diagnosis. The findings remained after adjusting for obesity and high blood lipids. Obesity was significantly more common in patients with endometrial, colon and kidney cancer and with breast cancer above the age of 60 years in those where obesity was diagnosed close to the diagnosis of cancer. High blood lipids were significantly more common in patients with ovarian cancer and less common in patients with breast cancer.
CONCLUSIONS: The study confirms some previous findings concerning comorbidity and cancer and highlights some new ones.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22467266     DOI: 10.1007/s10552-012-9946-5

Source DB:  PubMed          Journal:  Cancer Causes Control        ISSN: 0957-5243            Impact factor:   2.506


  18 in total

1.  Screening rates for colorectal cancer in Canada: a cross-sectional study.

Authors:  Harminder Singh; Charles N Bernstein; Jewel N Samadder; Rashid Ahmed
Journal:  CMAJ Open       Date:  2015-04-02

2.  Diabetes mellitus and the risk of urolithiasis: a meta-analysis of observational studies.

Authors:  Lu Hao Liu; Ran Kang; Jun He; Shan Kun Zhao; Fu Tian Li; Zhi Gang Zhao
Journal:  Urolithiasis       Date:  2015-04-17       Impact factor: 3.436

Review 3.  Glycolytic genes in cancer cells are more than glucose metabolic regulators.

Authors:  Zhe-Yu Hu; Lanbo Xiao; Ann M Bode; Zigang Dong; Ya Cao
Journal:  J Mol Med (Berl)       Date:  2014-06-08       Impact factor: 4.599

4.  Association Between Diabetes and the Risk of Kidney Cancer: Systematic Review and Meta-Analysis.

Authors:  Andrés Bonilla-Sanchez; Jenny Rojas-Munoz; Herney Andrés Garcia-Perdomo
Journal:  Clin Diabetes       Date:  2022

Review 5.  Obesity, Physical Activity and Bladder Cancer.

Authors:  Jonathan L Noguchi; Michael A Liss; J Kellogg Parsons
Journal:  Curr Urol Rep       Date:  2015-10       Impact factor: 3.092

Review 6.  Diabetes mellitus increases the risk of bladder cancer: an updated meta-analysis of observational studies.

Authors:  Hong Fang; Baodong Yao; Yujie Yan; Huilin Xu; Yinan Liu; Hongmei Tang; Jie Zhou; Lili Cao; Weijie Wang; Jinling Zhang; Liyun Zhao; Xi Chen; Fen Zhang; Yanping Zhao
Journal:  Diabetes Technol Ther       Date:  2013-11       Impact factor: 6.118

7.  Risk of bladder cancer in patients with diabetes: a retrospective cohort study.

Authors:  Maria E Goossens; Maurice P Zeegers; Marloes T Bazelier; Marie L De Bruin; Frank Buntinx; Frank de Vries
Journal:  BMJ Open       Date:  2015-06-01       Impact factor: 2.692

8.  Type 2 diabetes mellitus, oral diabetic medications, insulin therapy, and overall breast cancer risk.

Authors:  Hala Ahmadieh; Sami T Azar
Journal:  ISRN Endocrinol       Date:  2013-01-17

9.  Diabetes mellitus and risk of bladder cancer: a meta-analysis of cohort studies.

Authors:  Xin Xu; Jian Wu; Yeqing Mao; Yi Zhu; Zhenghui Hu; Xianglai Xu; Yiwei Lin; Hong Chen; Xiangyi Zheng; Jie Qin; Liping Xie
Journal:  PLoS One       Date:  2013-03-05       Impact factor: 3.240

10.  Long-Term Diabetes Mellitus Is Associated with an Increased Risk of Pancreatic Cancer: A Meta-Analysis.

Authors:  Shanshan Song; Baosheng Wang; Xin Zhang; Liliang Hao; Xianliang Hu; Zhongxiang Li; Shaolong Sun
Journal:  PLoS One       Date:  2015-07-29       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.